KM Pharma expands skincare and global business, recruits production, logistics and sales talent
Predicted impact: Low· Actual: +9.2% vs sector, volume 0.0× normal (5 trading days)
Hiring drive and business expansion plans; no financial size given.
Kmpharmaceutical케이엠제약
225430 · KOSDAQ · ₩225430 · 케이엠제약
₩698 ₩0 (0.00%)End-of-day · Oct 27, 2026 · End-of-day prices.
Price · 1Y −77.34%
- Market cap
- ₩4.5B
- Enterprise value
- ₩16B
- P/E
- —
- P/B
- 0.2×
- Dividend yield
- 0.0%
- ROE
- −14.1%
- Net margin
- −22.2%
Trailing 12 months from filed financial statements, as of H1 2026. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.
52-week range−89.8% from the high
₩508Today: ₩698 – ₩698₩6,850
Returns
- 1W0.0%
- 1M0.0%
- 3M−52.0%
- 6M−73.0%
- YTD−74.1%
- 1Y−77.3%
- Volume today
- —
- Traded today
- —
- Listed shares
- 6,485,675
- EPS (12 months)
- −₩580
- Earnings yield −83.1%
AI researchResearch being writtenOur AI is writing a report on this company from filed data, prices and news. Check back soon.
Upcoming dates
Full calendar →🎁 Gift this stock
Send a friend ₩100,000 of paper money in this stock. They get it when they join.
Signals
Quiet- BuzzQuietBuzz 43 of 100 (50 is a normal day for this stock).
- MomentumFlat0% over the last month; the price is below its 20-day average.
- News impactLow1 news items and filings in two weeks; 0 rated high impact, 0 medium.
Signals describe activity, not recommendations. Not financial advice.
Kmpharmaceutical stock overview
Kmpharmaceutical (케이엠제약, KRX: 225430) is listed on KOSDAQ, in the Chemicals sector. The company manufactures and sells personal care and household products in Korea, including oral care products such as toothpaste, toothbrushes and mouthwash for infants and adults, beauty care products such as shampoo, body wash and skincare, and other household goods such as tissues, masks, hand sanitizers and health supplements. Its shares closed at ₩698 on Oct 27, 2026, unchanged on the day, giving it a market value of ₩4.5B.
Key facts
- Market cap
- ₩4.5B
- Sector
- Chemicals
- Latest price change
- 0.00%
- As of
- Oct 27, 2026
- Main business
- The company manufactures and sells personal care and household products in Korea, including oral care products such as toothpaste, toothbrushes and mouthwash for infants and adults, beauty care products such as shampoo, body wash and skincare, and other household goods such as tissues, masks, hand sanitizers and health supplements.
Quick answers about Kmpharmaceutical
- What does Kmpharmaceutical do?
- The company manufactures and sells personal care and household products in Korea, including oral care products such as toothpaste, toothbrushes and mouthwash for infants and adults, beauty care products such as shampoo, body wash and skincare, and other household goods such as tissues, masks, hand sanitizers and health supplements. Its character-licensed lines include Pororo and Tayo brands, and it also provides OEM/ODM manufacturing for retailers and other companies. It sells through large discount stores, supermarkets, drugstores and online channels in Korea and exports to other countries.
- What is the market cap of Kmpharmaceutical?
- The market capitalisation of Kmpharmaceutical was ₩4.5B at the close on Oct 27, 2026.
- Who are the largest shareholders of Kmpharmaceutical?
- According to the latest official filings, the largest reported holders are Kang Il-mo (49.66%, as of Oct 8, 2026); BAIK BRIAN SEUNG WON (Baek Seung-won) (15.45%, as of Jul 30, 2026); Hwang Min-yeong (0.95%, as of Sep 16, 2026).
- When is the next earnings report from Kmpharmaceutical?
- Korean companies rarely announce results dates in advance. Based on when Kmpharmaceutical filed the same report in past years, its next 3q results is expected around Nov 14, 2026.
Company profile
The company manufactures and sells personal care and household products in Korea, including oral care products such as toothpaste, toothbrushes and mouthwash for infants and adults, beauty care products such as shampoo, body wash and skincare, and other household goods such as tissues, masks, hand sanitizers and health supplements. Its character-licensed lines include Pororo and Tayo brands, and it also provides OEM/ODM manufacturing for retailers and other companies. It sells through large discount stores, supermarkets, drugstores and online channels in Korea and exports to other countries.
Written by AI from the company's latest annual report.
- Korean name
- 케이엠제약
- Sector
- Chemicals
- Themes
- Pharmaceuticals
- CEO
- 백승원(BAIK BRIAN SEUNG WON)
- Founded
- Jul 2015
- Listed
- Oct 2015
- Listed shares
- 6,485,675
- Fiscal year ends
- Month 12
- Website
- kmkmp.com
Similar companies
- LG Chem051910 · ₩16T₩228,500+1.56%
- Hanwha Solutions009830 · ₩5.8T₩25,850−2.45%
- Hanwha000880 · ₩4.9T₩92,700+1.64%
- SKC011790 · ₩4.1T₩83,200+5.18%
- KCC002380 · ₩3.2T₩377,000+2.45%
- Kumho Petro Chemical011780 · ₩2.6T₩106,000+3.41%
- Soulbrain357780 · ₩2.4T₩307,000+6.41%
- ISU Specialty Chemical457190 · ₩2.2T₩73,400+4.26%
Recent news
Recent filings
See all- [Amended] Report on Results of Acquisition of Treasury StockOct 23, 2026
- 5%+ holding reportOct 8, 2026
- Trading haltOct 2, 2026
- Other management mattersOct 2, 2026
- 5%+ holding reportSep 16, 2026
Titles in Korean until English translations are added.
Also known as: Kmpharmaceutical / 케이엠제약 / 225430 / KRX:225430
Source: KRX statistical information